Trial intelligence / Profile preview

Albendazole Treatment for Toxocariasis in Children in Ho Chi Minh City

NCT05208333Unknown

Sponsor
Pham Ngoc Thach University of Medicine
Start
May 2022
Primary completion
Dec 2023
Modality
Small Molecules
01

Overview

Open-label, single-arm trial of albendazole in toxocariasis, sponsored by Pham Ngoc Thach University of Medicine. Primary endpoint: Procedures Guidelines for diagnosis, treatment, and post-treatment follow-up of Toxocariasis larvae at 12 months. Status: unknown.

02

Drugs

albendazole
03

Conditions

toxocariasis

Beyond the preview

Go deeper on NCT05208333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05208333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call